TGFB1 and metabolic disease: Importantly, recent RNA sequencing data of KS transcriptomes compared to KS lesions show KSHV-mediated global transcriptional reprogramming that, similarly to our MSC tumors, included upregulation of the transforming growth factor-beta 1 (TGFB1) signaling pathway and glucose metabolism disorders [43].